| For: | Garcovich S, Garcovich M, Capizzi R, Gasbarrini A, Zocco MA. Cutaneous manifestations of hepatitis C in the era of new antiviral agents. World J Hepatol 2015; 7(27): 2740-2748 [PMID: 26644817 DOI: 10.4254/wjh.v7.i27.2740] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v7/i27/2740.htm |
| Number | Citing Articles |
| 1 |
Gislaine Silveira Olm. Dermatology in Public Health Environments. 2018; doi: 10.1007/978-3-319-33919-1_40
|
| 2 |
Lucija Kuna, Jelena Jakab, Robert Smolic, George Y Wu, Martina Smolic. HCV Extrahepatic Manifestations. Journal of Clinical and Translational Hepatology 2019; 7(X) doi: 10.14218/JCTH.2018.00049
|
| 3 |
Nancy S. Handler, Marc Z. Handler, Matthew P. Stephany, Glenn A. Handler, Robert A. Schwartz. Porphyria cutanea tarda: an intriguing genetic disease and marker. International Journal of Dermatology 2017; 56(6) doi: 10.1111/ijd.13580
|
| 4 |
Gema Lledó, Laura Benítez-Gutiérrez, Ana Arias, Silvia Requena, Valentín Cuervas-Mons, Carmen de Mendoza. Benefits of Hepatitis C Cure With Antivirals: Why Test and Treat?. Future Microbiology 2019; 14(5) doi: 10.2217/fmb-2019-0041
|
| 5 |
V. V. Onipchenko, I. G. Sergeeva, Yu. M. Krinitsyina, A. A. Kondrashova, V. V. Pahomova, N. V. Hismatulina. Anti-cytokine therapy of a patient suffering from psoriatic arthritis. Vestnik dermatologii i venerologii 2016; 92(4) doi: 10.25208/0042-4609-2016-92-4-54-58
|
| 6 |
B Bruzzone, O Magnani, L Sticchi, P Canepa, E Rappazzo, G Icardi, M Setti. Resolution of porphyria cutanea tarda in HIV and mixed HCV coinfection after direct-acting antiviral (DAA) therapy. Journal of Antimicrobial Chemotherapy 2017; 72(10) doi: 10.1093/jac/dkx222
|
| 7 |
Gislaine Silveira Olm. Dermatology in Public Health Environments. 2023; doi: 10.1007/978-3-031-13505-7_50
|
| 8 |
Mehmet Sayiner, Pegah Golabi, Freba Farhat, Zobair M. Younossi. Dermatologic Manifestations of Chronic Hepatitis C Infection. Clinics in Liver Disease 2017; 21(3) doi: 10.1016/j.cld.2017.03.010
|
| 9 |
Manasvi Gupta, Manik Aggarwal, Neetu Bhari. Acneiform eruptions: An unusual dermatological side effect of ribavirin. Dermatologic Therapy 2018; 31(5) doi: 10.1111/dth.12679
|
| 10 |
Massimo Galli, Giuseppe Monti, Piero Marson, Patrizia Scaini, Maurizio Pietrogrande, Marco Candela, Laura Castelnovo, Paola Faggioli, Paola Novati, Roberta Zani, Maria Teresa Mascia, Francesco Saccardo, Cesare Mazzaro, Piercarlo Sarzi-Puttini, Marco Sebastiani, Luca Quartuccio, Salvatore De Vita. Recommendations for managing the manifestations of severe and life-threatening mixed cryoglobulinemia syndrome. Autoimmunity Reviews 2019; 18(8) doi: 10.1016/j.autrev.2019.06.008
|
| 11 |
A.A. Khryanin, A.V. Sokolovskaia, V.K. Bocharova. Lichen planus associated with viral hepatitis C: new data, concepts and hypotheses. Russian Journal of Clinical Dermatology and Venereology 2023; 22(4) doi: 10.17116/klinderma202322041426
|
| 12 |
Catherine A. Harwood, Jane C. Sterling. Rook's Textbook of Dermatology. 2024; doi: 10.1002/9781119709268.rook025
|
| 13 |
F.B. Oliveira, J.C. Boza, G.C. Pires, C.R. Barone, S.D. Rossi, M. Silva, R.R. Bonamigo. Direct‐acting antiviral drugs are triggers for psoriasis: report of three cases. International Journal of Dermatology 2018; 57(10) doi: 10.1111/ijd.14137
|
| 14 |
|
| 15 |
Joana Rigor, Sara Almeida Pinto, Daniela Martins-Mendes. Porphyrias: A clinically based approach. European Journal of Internal Medicine 2019; 67 doi: 10.1016/j.ejim.2019.06.014
|
| 16 |
Yasmin Mostafa Tawfik, Sahar M. Hassany, Aya Y. Badran, Amira F. El‐Gazzar, Mohamed F. Alemam, Doaa S. Sayed. Hepatitis C virus associated skin manifestations in upper Egypt: Before and after direct acting antiviral treatment. Dermatologic Therapy 2020; 33(6) doi: 10.1111/dth.14365
|
| 17 |
Anna Linda Zignego, Manuel Ramos-Casals, Clodoveo Ferri, David Saadoun, Luca Arcaini, Dario Roccatello, Alessandro Antonelli, Anne Claire Desbois, Cloe Comarmond, Laura Gragnani, Milvia Casato, Peter Lamprecht, Alessandra Mangia, Athanasios G Tzioufas, Zobair M Younossi, Patrice Cacoub. International therapeutic guidelines for patients with HCV-related extrahepatic disorders. A multidisciplinary expert statement. Autoimmunity Reviews 2017; 16(5) doi: 10.1016/j.autrev.2017.03.004
|
| 18 |
|
| 19 |
Umer Ansari, Lauren I. Henderson, Geraldine Stott, Karina Parr. Treatment with ledipasvir-sofosbuvir for hepatitis C resulting in improvement of lichen planus. JAAD Case Reports 2017; 3(1) doi: 10.1016/j.jdcr.2016.12.005
|
| 20 |
Ashwani K. Singal, Krishna V.R. Venkata, Sarat Jampana, Fakhar-Ul Islam, Karl E. Anderson. Hepatitis C Treatment in Patients With Porphyria Cutanea Tarda. The American Journal of the Medical Sciences 2017; 353(6) doi: 10.1016/j.amjms.2017.03.007
|
| 21 |
Ayman Abdelmaksoud. Anti-HCV for porphyria cutanea tarda. Dermatologic Therapy 2017; 30(3) doi: 10.1111/dth.12466
|
| 22 |
Uyen Ngoc Mui, Christopher T. Haley, Ramya Vangipuram, Stephen K. Tyring. Human oncoviruses: Mucocutaneous manifestations, pathogenesis, therapeutics, and prevention. Journal of the American Academy of Dermatology 2019; 81(1) doi: 10.1016/j.jaad.2018.10.072
|
| 23 |
Busara Songtanin, Kenneth Nugent. Burden, Outcome, and Comorbidities of Extrahepatic Manifestations in Hepatitis C Virus Infection. Biology 2022; 12(1) doi: 10.3390/biology12010023
|
| 24 |
Simona Georgescu, Mircea Tampa, Madalina Mitran, Cristina Mitran, Maria Sarbu, Ilinca Nicolae, Clara Matei, Constantin Caruntu, Monica Neagu, Mircea Popa. Potential pathogenic mechanisms involved in the association between lichen planus and hepatitis C virus infection (Review). Experimental and Therapeutic Medicine 2018; doi: 10.3892/etm.2018.6987
|
| 25 |
N. N. Potekaev, L. L. Karpov, O. V. Dolya, M. N. Markova. Late skin porphyria as a rare case of extrahepatic manifestations of chronic hepatitis C in a patient with a history of syphilis. Klinicheskaya dermatologiya i venerologiya 2018; 17(5) doi: 10.17116/klinderma201817051119
|
| 26 |
Sayan Malakar, Saurabh Mishra, Sumit Rungta, Arvind Kumar, Amar Deep. Frequency of dermatological manifestations in patients with chronic hepatitis C infections. Indian Journal of Gastroenterology 2026; 45(4) doi: 10.1007/s12664-025-01843-y
|
| 27 |
Dario Di Stasio, Alberta Lucchese, Antonio Romano, Luigi Elio Adinolfi, Rosario Serpico, Aldo Marrone. The clinical impact of direct-acting antiviral treatment on patients affected by hepatitis C virus-related oral lichen planus: a cohort study. Clinical Oral Investigations 2022; 26(8) doi: 10.1007/s00784-022-04507-9
|
| 28 |
Clodoveo Ferri, Manuel Ramos-Casals, Anna Linda Zignego, Luca Arcaini, Dario Roccatello, Alessandro Antonelli, David Saadoun, Anne Claire Desbois, Marco Sebastiani, Milvia Casato, Peter Lamprecht, Alessandra Mangia, Athanasios G Tzioufas, Zobair M Younossi, Patrice Cacoub. International diagnostic guidelines for patients with HCV-related extrahepatic manifestations. A multidisciplinary expert statement. Autoimmunity Reviews 2016; 15(12) doi: 10.1016/j.autrev.2016.09.006
|
| 29 |
Mohamed El Kassas, Osama MO Hegazy, Eman M Salah. Effect of treating chronic hepatitis C with direct-acting antivirals on extrahepatic cutaneous manifestations. World Journal of Hepatology 2020; 12(10): 841-849 doi: 10.4254/wjh.v12.i10.841
|
| 30 |
Ali Al Bshabshe, Wesam F. Mousa, Nashwa Nor El-Dein. An Overview of Clinical Manifestations of Dermatological Disorders in Intensive Care Units: What Should Intensivists Be Aware of?. Diagnostics 2023; 13(7) doi: 10.3390/diagnostics13071290
|
| 31 |
Yumiko Nagao, Kanae Kimura, Yuji Kawahigashi, Michio Sata. Successful Treatment of Hepatitis C Virus-associated Oral Lichen Planus by Interferon-free Therapy with Direct-acting Antivirals. Clinical and Translational Gastroenterology 2016; 7(7) doi: 10.1038/ctg.2016.37
|
| 32 |
Brandon Block, Jaanvi Mehta, Gabriela Soto‐Canetti, Alice Tang, Riley Spingler, Benjamin Ungar, Jordan Talia. Association Between Type I Interferonopathies and the Development of Cutaneous Sarcoidosis, Morphea, Lichen Planus and Granuloma Annulare: A Retrospective Cohort Study. Experimental Dermatology 2026; 35(6) doi: 10.1111/exd.70295
|
| 33 |
Mohamed El Kassas, Mohamed Naguib Wifi, Reem Mahdy, Shimaa Afify, Enas Hafez, Yasmeen Abd El Latif, Marwa Ezzat, Adel El Tahan, Naglaa Youssef, Gamal Esmat. Herpes Zoster reactivation in patients with chronic hepatitis C under treatment with directly acting antiviral agents: A case series. Arab Journal of Gastroenterology 2017; 18(1) doi: 10.1016/j.ajg.2017.02.003
|
| 34 |
Alejandro A. Gru, Andrea L. Salavaggione. Lichenoid and interface dermatoses. Seminars in Diagnostic Pathology 2017; 34(3) doi: 10.1053/j.semdp.2017.03.001
|
| 35 |
Adhyatm Bhandari, Rahul Mahajan. Skin Changes in Cirrhosis. Journal of Clinical and Experimental Hepatology 2022; 12(4) doi: 10.1016/j.jceh.2021.12.013
|
| 36 |
Lina Maria Mejia. Oral Manifestations of Gastrointestinal Disorders. Atlas of the Oral and Maxillofacial Surgery Clinics 2017; 25(2) doi: 10.1016/j.cxom.2017.04.002
|
| 37 |
Essam Al Ageeli, Jawaher A. Abdulhakim, Mohammad H. Hussein, Maryam M. Alnoman, Samia S. Alkhalil, Peter P. Issa, Nader A. Nemr, Ahmed Abdelmaksoud, Dhaifallah A. Alenizi, Manal S. Fawzy, Eman A. Toraih. The HCV-Melanoma Paradox: First Multi-Cohort and Molecular Net-Work Analysis Reveals Lower Incidence but Worse Outcomes—Integrating Clinical, Real-World, and In Silico Data. Medicina 2024; 60(9) doi: 10.3390/medicina60091531
|